News

In connection with the exercise of its option, King has paid Acura an option exercise fee of $3 million. Products utilizing Aversion technology are designed to deter common

According to the company, Gleevec is now the only post-surgery treatment indicated to delay the return of this highly aggressive cancer, filling a major need for gastrointestinal stromal

The acquisition is expected to expand Medtronic’s surgical technologies business unit portfolio of treatments for sleep-disordered breathing. The Repose Genioglossus Advancement and Hyoid Advancement (GAHA) surgical devices advance

Brian Sheridan, general counsel of the Sorin Group, said: “This settlement, following the US District Court’s denial of ATS’s motion to dismiss, is very favorable to Sorin Group.

Prior to Iomai, he served as president and CEO of Procept, a publicly traded immunology company, as vice president, corporate development at Integrated Genetics (now Genzyme), and in

Mr Moch is the founder and president of Euclidean Life Science Advisors, which provides strategic advisory services to life sciences companies. He is a former managing director of

Thomas Smith, vice president of medical affairs at Teva Neuroscience, said: “The thinner, 29-gauge needle further demonstrates Teva’s commitment to continued research and development of Copaxone to help

Trinity has recently obtained CE marking which enables it to sell the Destiny Max in Europe and has now filed its 510k submission with the FDA seeking permission

According to the company, the new funds will be used to progress its acquisition plan and to establish its US operations in South Carolina to expand its presence